Narayan K M Venkat, Varghese Jithin Sam, Beyh Yara S, Bhattacharyya Soura, Khandelwal Shweta, Krishnan Gokul S, Siegel Karen R, Thomas Tinku, Kurpad Anura V
Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322 USA.
Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, GA 30322 USA.
J Indian Inst Sci. 2023 Mar 21:1-22. doi: 10.1007/s41745-022-00354-5.
Indian people are at high risk for type 2 diabetes (T2DM) even at younger ages and lower body weights. Already 74 million people in India have the disease, and the proportion of those with T2DM is increasing across all strata of society. Unique aspects, related to lower insulin secretion or function, and higher hepatic fat deposition, accompanied by the rise in overweight (related to lifestyle changes) may all be responsible for this unrelenting epidemic of T2DM. Yet, research to understand the causes, pathophysiology, phenotypes, prevention, treatment, and healthcare delivery of T2DM in India seriously lags behind. There are major opportunities for scientific discovery and technological innovation, which if tapped can generate solutions for T2DM relevant to the country's context and make leading contributions to global science. We analyze the situation of T2DM in India, and present a four-pillar (etiology, precision medicine, implementation research, and health policy) strategic research framework to tackle the challenge. We offer key research questions for each pillar, and identify infrastructure needs. India offers a fertile environment for shifting the paradigm from imprecise late-stage diabetes treatment toward early-stage precision prevention and care. Investing in and leveraging academic and technological infrastructures, across the disciplines of science, engineering, and medicine, can accelerate progress toward a diabetes-free nation.
印度人即使在较年轻的年龄和较低的体重下,患2型糖尿病(T2DM)的风险也很高。印度已经有7400万人患有这种疾病,而且T2DM患者在社会各阶层中的比例都在上升。与胰岛素分泌或功能降低以及肝脏脂肪沉积增加相关的独特因素,再加上超重(与生活方式改变有关)的增加,可能都是导致T2DM这种持续蔓延的流行病的原因。然而,在印度,关于T2DM的病因、病理生理学、表型、预防、治疗和医疗服务提供的研究严重滞后。存在重大的科学发现和技术创新机会,如果加以利用,可以产生与该国情况相关的T2DM解决方案,并为全球科学做出重要贡献。我们分析了印度T2DM的情况,并提出了一个四支柱(病因学、精准医学、实施研究和卫生政策)战略研究框架来应对这一挑战。我们为每个支柱提出了关键研究问题,并确定了基础设施需求。印度为将范式从不精确的晚期糖尿病治疗转向早期精准预防和护理提供了肥沃的环境。投资并利用科学、工程和医学等学科的学术和技术基础设施,可以加速迈向无糖尿病国家的进程。